Annual CFF:
$25.85M-$144.62M(-84.83%)Summary
- As of today, PTGX annual cash from financing is $25.85 million, with the most recent change of -$144.62 million (-84.83%) on December 31, 2024.
- During the last 3 years, PTGX annual cash from financing has fallen by -$104.07 million (-80.10%).
- PTGX annual cash from financing is now -89.56% below its all-time high of $247.63 million, reached on December 31, 2020.
Performance
PTGX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$2.92M-$8.52M(-74.44%)Summary
- As of today, PTGX quarterly cash from financing is $2.92 million, with the most recent change of -$8.52 million (-74.44%) on June 30, 2025.
- Over the past year, PTGX quarterly cash from financing has increased by +$353.00 thousand (+13.72%).
- PTGX quarterly cash from financing is now -97.70% below its all-time high of $126.98 million, reached on December 31, 2020.
Performance
PTGX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$30.45M+$353.00K(+1.17%)Summary
- As of today, PTGX TTM cash from financing is $30.45 million, with the most recent change of +$353.00 thousand (+1.17%) on June 30, 2025.
- Over the past year, PTGX TTM cash from financing has dropped by -$15.16 million (-33.24%).
- PTGX TTM cash from financing is now -88.33% below its all-time high of $261.02 million, reached on June 30, 2021.
Performance
PTGX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PTGX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -84.8% | +13.7% | -33.2% |
| 3Y3 Years | -80.1% | +330.1% | +43.9% |
| 5Y5 Years | -43.8% | -97.4% | -76.7% |
PTGX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -84.8% | +37.2% | -97.3% | +455.0% | -82.1% | +61.6% |
| 5Y | 5-Year | -89.6% | +37.2% | -97.7% | +455.0% | -88.3% | +61.6% |
| All-Time | All-Time | -89.6% | +187.2% | -97.7% | +443.3% | -88.3% | +8558.3% |
PTGX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.92M(-74.4%) | $30.45M(+1.2%) |
| Mar 2025 | - | $11.44M(+183.9%) | $30.10M(+16.4%) |
| Dec 2024 | $25.85M(-84.8%) | $4.03M(-66.6%) | $25.85M(+15.7%) |
| Sep 2024 | - | $12.05M(+368.5%) | $22.35M(-51.0%) |
| Jun 2024 | - | $2.57M(-64.3%) | $45.61M(-69.8%) |
| Mar 2024 | - | $7.20M(+1266.0%) | $151.21M(-11.3%) |
| Dec 2023 | $170.48M(+805.0%) | $527.00K(-98.5%) | $170.48M(-0.0%) |
| Sep 2023 | - | $35.31M(-67.4%) | $170.50M(+25.5%) |
| Jun 2023 | - | $108.17M(+308.8%) | $135.87M(+378.8%) |
| Mar 2023 | - | $26.46M(+4685.4%) | $28.38M(+50.6%) |
| Dec 2022 | $18.84M(-85.5%) | $553.00K(-18.7%) | $18.84M(-7.9%) |
| Sep 2022 | - | $680.00K(0.0%) | $20.46M(-3.3%) |
| Jun 2022 | - | $680.00K(-96.0%) | $21.16M(-85.5%) |
| Mar 2022 | - | $16.93M(+678.9%) | $145.87M(+12.3%) |
| Dec 2021 | $129.92M(-47.5%) | $2.17M(+57.3%) | $129.92M(-49.0%) |
| Sep 2021 | - | $1.38M(-98.9%) | $254.73M(-2.4%) |
| Jun 2021 | - | $125.39M(>+9900.0%) | $261.02M(+5.2%) |
| Mar 2021 | - | $979.00K(-99.2%) | $248.21M(+0.2%) |
| Dec 2020 | $247.63M | $126.98M(+1555.8%) | $247.63M(+89.9%) |
| Sep 2020 | - | $7.67M(-93.2%) | $130.42M(-11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $112.58M(>+9900.0%) | $147.99M(+221.4%) |
| Mar 2020 | - | $399.00K(-95.9%) | $46.05M(+0.0%) |
| Dec 2019 | $46.04M(+90.9%) | $9.78M(-61.3%) | $46.04M(+25.3%) |
| Sep 2019 | - | $25.24M(+137.4%) | $36.74M(+6.4%) |
| Jun 2019 | - | $10.63M(+2625.6%) | $34.53M(+44.0%) |
| Mar 2019 | - | $390.00K(-18.6%) | $23.98M(-0.6%) |
| Dec 2018 | $24.11M(-63.2%) | $479.00K(-97.9%) | $24.11M(-72.8%) |
| Sep 2018 | - | $23.03M(>+9900.0%) | $88.70M(+35.0%) |
| Jun 2018 | - | $74.00K(-86.0%) | $65.70M(-0.0%) |
| Mar 2018 | - | $530.00K(-99.2%) | $65.71M(+0.2%) |
| Dec 2017 | $65.55M(-38.3%) | $65.06M(>+9900.0%) | $65.55M(>+9900.0%) |
| Sep 2017 | - | $31.00K(-64.4%) | -$360.00K(-100.4%) |
| Jun 2017 | - | $87.00K(-76.7%) | $84.89M(+1.0%) |
| Mar 2017 | - | $374.00K(+143.9%) | $84.05M(-20.9%) |
| Dec 2016 | $106.31M(+510.3%) | -$852.00K(-101.0%) | $106.31M(-0.8%) |
| Sep 2016 | - | $85.28M(>+9900.0%) | $107.16M(+389.7%) |
| Jun 2016 | - | -$750.00K(-103.3%) | $21.88M(-3.3%) |
| Mar 2016 | - | $22.63M(>+9900.0%) | $22.63M(>+9900.0%) |
| Dec 2015 | $17.42M(+93.5%) | $0.00(-100.0%) | $2000.00(0.0%) |
| Mar 2015 | - | $2000.00 | $2000.00 |
| Dec 2014 | $9.00M | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Protagonist Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of PTGX is $25.85M
What is the all-time high annual cash from financing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual cash from financing is $247.63M
What is Protagonist Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, PTGX annual cash from financing has changed by -$144.62M (-84.83%)
What is Protagonist Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of PTGX is $2.92M
What is the all-time high quarterly cash from financing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly cash from financing is $126.98M
What is Protagonist Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, PTGX quarterly cash from financing has changed by +$353.00K (+13.72%)
What is Protagonist Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of PTGX is $30.45M
What is the all-time high TTM cash from financing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM cash from financing is $261.02M
What is Protagonist Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, PTGX TTM cash from financing has changed by -$15.16M (-33.24%)